Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 4 recruiting now small index

Hearing Aids clinical trials

4 of 5 indexed Hearing Aids trials are currently recruiting.

Corpus placement: #3,391 of 28,707 conditions by registered trial count.

5 US clinical trials · 4 currently recruiting · #3,391 of 28,707 conditions by registered trial count

Hearing Aids: 5 US clinical trials tracked, 4 recruiting.

Hearing Aids is the subject of 5 registered US clinical trials on ClinicalTrials.gov, 4 of them currently open to new participants. The most active sponsor is The University of Texas at Dallas, running 1 of these trials.

Enrollment posture brief

Registry condition hearing-aids

OPEN 4 | RECR 80% | LATE 0 | EARLY 0 | RANK #3391 | SPON 1

Nearest open-share peer: Acute Leukemia of Ambiguous Lineage (80% recruiting · 10 trials)

Ablation80%ACL Reconstruction80%Hearing Aids (this)80%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near Hearing Aids

Hearing Aids lists 4 open slots (80% of 5 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Hearing Aids on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Hearing Aids is recruiting above its size-band peers.

    4 of 5 indexed trials (80%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Hearing Aids research.

    The University of Texas at Dallas accounts for 1 of 5 trials (20%). 5 distinct sponsors appear on at least one study for this condition label.

  3. Typical Hearing Aids enrolment sits around 121 participants.

    Median target enrolment is 121 among the 5 trials that report a genuine target (sentinel values excluded). 2 of those (40%) plan for fewer than 100 participants.

  4. Hearing Aids research is mostly interventional.

    5 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase Distribution

Phase data not available

Named interventions

Most-linked intervention names on Hearing Aids records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Hearing Aids Device
1 trials
Airpod Pro as hearing assistive technology Device
1 trials
BTE hearing aid with compatible earmolds Device
1 trials
Open-source master hearing aid Device
1 trials
OTC-SF Device
1 trials
OTC-R Device
1 trials
OTC-HCP Device
1 trials
HA-HCP Device
1 trials

US sites by state

Facility locations filed on Hearing Aids trials. A trial with sites in several states counts in each.

Texas 2 trials
Illinois 1 trials
Florida 1 trials
Colorado 1 trials
Arizona 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Hearing Aids page

5 registered trials, 4 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Hearing Aids condition card totals 5 registered trials; most-linked intervention Hearing Aids; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.